This suggests that in GATA3-deficient tumor cells, the acquisition of mesenchymal traits by the activation of Fra1 is dominant over the loss of epithelial features by the deficiency of c-Fos, in activating EMT and driving CSC function. This evidence concerns the gene GATA3 and neoplasm.